Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colitis, Ulcerative 4Inflammatory Bowel Diseases 3Crohn Disease 3Arthritis, Rheumatoid 3Graft vs Host Disease 2Cachexia 2Anorexia 2Recurrence 1Rare Diseases 1Psoriasis 1Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Kidney Transplantation 1Inflammation 1Hypertension 1Gastrointestinal Diseases 1Fatigue 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1Arthritis, Psoriatic 1Anemia 1

Interventions

Therapeutics 20Exercise 16Yoga 15Modafinil 12Surveys and Questionnaires 11Psychiatric Rehabilitation 10Methylphenidate 7Acupuncture Therapy 7Therapeutic Touch 6Ultraviolet Therapy 5Educational Status 5Acceptance and Commitment Therapy 5Walking 4Sugars 4Physical Therapy Modalities 4Palliative Care 4Early Intervention, Educational 4Control Groups 4Behavior Therapy 4methyl hydroxyethyl cellulose 3Touch 3Exercise Therapy 3Epoetin Alfa 3Counseling 3Acupressure 3Standard of Care 2Sodium Chloride 2Resistance Training 2Qigong 2Music Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fatigue × Infliximab × Clear all
NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Alliance for Clinical Trials in Oncology

Phase 3 Completed
67 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡